| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8536538 | Pharmacological Research | 2018 | 21 Pages |
Keywords
ECMBET inhibitorRTKCA9PDXNUT midline carcinomaNMCHIFGSEACMAPHDACiPROTACEREBRDDCISIBCPARPiHER2CSCRNAPIIBETITNBCAMLRNA polymerase IIPatient-derived xenograftBromodomainGene Set Enrichment AnalysisEMTAnti-cancer drugsTriple negative breast cancerBreast cancerInflammatory breast cancercancer stem cellestrogen response elementHypoxia-inducible factorsuper-enhanceracute myeloid leukemiaExtracellular matrixPARP inhibitorhistone deacetylase inhibitorDrug synergyHistone acetyltransferaseDuctal carcinoma in situCarbonic anhydrase 9HATTranscriptional controlepithelial-to-mesenchymal transitionEstrogen receptorReceptor Tyrosine KinaseHuman epidermal growth factor receptor 2Progesterone receptor
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Jennifer M. Sahni, Ruth A. Keri,